Event Details

Date: 19 September 2024
Time: 7.00 – 8.30 am
Location: Park Hyatt Melbourne, 1 Parliament Square, Melbourne 3002
Hosted by: InGeNA
Sponsored by: Amazon Web Services

About the Event

The InGeNA Genomics Industry Breakfast, hosted in conjunction with GA4GH and sponsored by AWS, brings together key stakeholders in the genomics industry to discuss the global landscape of genomics and its integration into health systems. This invitation-only event offers a unique opportunity to engage with leading experts and explore the future of genomics research and implementation.

Featured Speakers & Panellists

Dr. Edwin Sandanaraj

Genomics Solutions Architect, Amazon Web Services (AWS)

Edwin Sandanaraj is the Genomics Solutions Architect at Amazon Web Services (AWS). With a Ph.D. in Neuro-Oncology genomics and over 20 years of experience in healthcare genomics data management and analysis, he brings a wealth of knowledge to accelerate precision genomics efforts in Asia-Pacific and Japan. Previous work experience include Illumina, Singapore-based academic medical centres, Agency for Science, Technology and Research (A*Star) and Eli Lilly pharmaceuticals as bioinformatics scientist; he developed genomics pipelines for personalized therapeutic strategies. Edwin authored more than 20 peer-reviewed genomics research papers and has been in the reviewer panel of AACR, Wiley, OUP, Elsevier and Springer.

Dr. Catalina Lopez-Correa

Chief Scientific Officer, Genome Canada

Dr. Lopez-Correa is the Chief Scientific Officer (CSO) at Genome Canada. She has dedicated her career to genomics and its transformative applications in life sciences in Canada and internationally. As CSO at Genome Quebec (2008-2015) and Genome BC (2015-2019), she was instrumental in developing competitive teams for research and innovation initiatives raising the profile of Canadian genomics on the global stage. Recently, as the Executive Director of the Canadian COVID19 Genomics Network (CanCOGeN) she led a $40M initiative to advance the use of genomics to understand and control the COVID19 pandemic. Now, as CSO of Genome Canada, she is taking genomics to the next level, by advancing the national and global implementation of genomic technologies. She also held the position of COO at Ruta N Medellin, driving innovation ecosystems to advance social and economic development in Colombia and Latin America. Prior to that, she held leadership positions at deCODE Genetics, and Eli Lilly and has played advisory roles at the European Commission, Innovative Medicine Initiatives and other private and public sector entities working in the application and implementation of genomics technologies
Dr. Lopez-Correa was diagnosed with breast cancer in April 2023. Since her diagnosis, she has been advocating for patients’ access to precision oncology and genomic testing. She has written blogs, participated in podcasts to increase awareness about the importance of genomics for the diagnosis, treatment and prognosis of cancer patients.
Dr. Lopez-Correa’s work has been recognized with several awards. Among others, in 2017 the Canadian Senate 150th Anniversary Medal, in 2013 the National Order of Merit from Colombia.

Monica Ferrie

Chief Executive Officer, Genetic Support Network of Victoria

Possibilities and potential bring together the threads of Monica’s career. Working with and for individuals, families, communities, organisations and sectors, committed to equity and fairness, for many years Monica has worked across the community, health, education, business and government sectors. Her journey in the health sector led her to become the CEO of the Genetic Support Network of Victoria in 2017 and soon after joining the Board of Directors at Asia Pacific Alliance of Rare Disease Organisations, Advocacy Beyond Borders and recently as a Rare Disease International Council Member. Monica is actively engaged on many Boards, Committees, Research Projects (CI and AI) and Advisory/Working Groups including HTAi Rare Disease and Developing Countries working groups , International Rare Disease Consortium Research, International Consortium on Newborn Sequencing, Involve Australia, National Patient Organisation Network – Australia, Genomics Industry Alliance – Australia, Patient Voice Initiative and the Victorian Government Health Information Sharing Management Group.

Maxime Hebrard

Senior Scientist at A*STAR – Genome Institute of Singapore

Maxime obtained his PhD in Bioinformatics in France in 2012, working in a clinical lab part of National Reference Center Rare Diseases of Montpellier (Maolya) with the focus on elucidate hereditary eye diseases. Early adoption of next generation sequencing technologies (NGS) allows the team to solve tedious cases. Trained at the Laboratory of Computer Science, Robotics and Microelectronics of Montpellier (LIRMM), Maxime gains deep understanding of NGS analysis and algorithmic. Moving at RIKEN, Japan in 2015, Maxime focused on data visualization and research environment development. Joining the National Precision Medicine program of Singapore in 2019, Maxime is now leading the infrastructure development including cloud computing, data storage and data sharing capabilities. He is also responsible of the genomic data generation and oversee release creation, quality assurance, quality control (QA/QC).

Agenda

Contact Information:

For further details about the event, please reach out to InGeNA at info@ingena.org. We look forward to seeing you at the event!